CytoSorbents Announces Availability of Preliminary Data Abst

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using...

Related Keywords

Germany , United States , Spain , Barcelona , Comunidad Autonoma De Cataluna , Efthymios Deliargyris , Eric Kim , Phillip Chan , Twitter , Us Department Of Health , Human Services , Material Command , National Institutes Of Health , Us Air , European Association For Cardio , Corporate Communications , European Union , Us Army , Facebook , Blood Institute , Cytosorbents Corporation , National Heart , Sorbents Corporation , European Association , Cardio Thoracic Surgery , Investigating Efficiency Of Hemoadsorption , Vasodilatory Shock , Cardiac Surgery Patients , European System , Cardiac Operative Risk Evaluation , Sequential Organ Failure Assessment , Hemoadsorption Reduces Sepsis Related Death , All Comers Undergoing Surgery , Infective Left Sided Endocarditis , C Reactive Protein , Chief Medical Officer , Chief Executive Officer , Device Designations , Use Authorization , Antithrombotic Removal System , National Institutes , Operations Command , Air Force Material Command , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Relations Contact , Investor Relations ,